FAQ
Signs of mild cognitive impairment (MCI) or memory loss may include:
- Misplacing things often
- Difficulty finding words to describe objects, express feelings
- Forgetting to attend important events
- Trouble reading, writing, and/or holding conversations
- Repeating the same questions or stories
- Feeling lost or disoriented in familiar places
- Neglecting of financial tasks, such as paying bills
You should consider applying for a memory-related clinical research study if you:
- Are between 50 - 80 years old
- Have a confirmed diagnosis of—or are suspected to have—any form of memory loss, including Alzheimer’s disease, dementia or mild cognitive impairment (MCI)
- Have a caregiver who would be willing to act as your research study partner and attend all sessions with you for the duration of a clinical trial
The information gleaned from clinical studies may help identify new treatment options in the future for people suffering from multiple forms of memory loss. Study participants are often connected to specialists who understand their situation and can help answer questions and address concerns. Participants in research studies can expect to enjoy a safe, caring clinical environment, be treated with kindness and respect, and have access to top quality care during the trial.
In almost all instances, there is no cost to participate in a clinical trial. Participants receive all study-related medical care and medications for the duration of the research study. Likewise in many instances, patients also enjoy benefits such as compensation for time and travel.
As all drugs and medical procedures carry a risk of side effects, the possibility that participants may experience some discomfort or other reactions during or after a clinical trial does exist. The study staff for that trial should explain these potential risks before participants decide whether to participate, and help address any concerns.
No. The requirements or eligibility criteria vary by clinical trial, and sponsors/clinical sites are constantly looking for various patient populations in order to test the efficacy of their investigational drugs. Further screening will determine whether you’re eligible to participate in an active clinical study, but if not, you will likely be a candidate for one in the future, in which case you may be contacted. At that point, and before a potential participant decides whether to take part in the study, the study staff will review the informed consent form with you and answer any questions. Once the consent form has been signed by the participant (you), the screening period of the study begins.
Participation in clinical trials is entirely voluntary. Even if you are already involved in the study, you can change your mind at any time for any reason.
If you are interested in learning more, please contact us at any time. You may email us at help@clinicalenrollment.com.